The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
Open accessAbstract
The antidiabetic drug metformin exerts chemopreventive and antineoplastic effects in many types of malignancies. However, the mechanisms responsible for metformin actions appear diverse and may differ in different types of cancer. Understanding the molecular and cellular mechanisms specific for different cancers is important to optimize strategy for metformin treatment in different cancer types. Here, we investigate the in vitro and in vivo effects of metformin on esophageal squamous cell carcinoma (ESCC) cells. Metformin selectively inhibited cell growth in ESCC tumor cells but not immortalized noncancerous esophageal epithelial cells. In addition to apoptosis, metformin triggered autophagy. Pharmacological or genetic inhibition of autophagy sensitized ESCC cells to metformin-induced apoptotic cell death. Mechanistically, signal transducer and activator of transcription 3 (Stat3) and its downstream target Bcl-2 was inactivated by metformin treatment. Accordingly, small interfering RNA (siRNA)-mediated Stat3 knockdown enhanced metformin-induced autophagy and apoptosis, and concomitantly enhanced the inhibitory effect of metformin on cell viability. Similarly, the Bcl-2 proto-oncogene, an inhibitor of both apoptosis and autophagy, was repressed by metformin. Ectopic expression of Bcl-2 protected cells from metformin-mediated autophagy and apoptosis. In vivo, metformin downregulated Stat3 activity and Bcl-2 expression, induced apoptosis and autophagy, and inhibited tumor growth. Together, inactivation of Stat3-Bcl-2 pathway contributes to metformin-induced growth inhibition of ESCC by facilitating crosstalk between apoptosis and autophagy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,577
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
Shimizu, S., Kanaseki, T., Mizushima, N., Mizuta, T., Arakawa-Kobayashi, S., Thompson, C. B., & Tsujimoto, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1192 · Cited by 1,358
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
The dynamic nature of autophagy in cancer
Kimmelman, A. C. (2011) · Genes & Development · doi:10.1101/gad.17558811 · Cited by 589
Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., Le Marchand-Brustel, Y., Giorgetti-Peraldi, S., Cormont, M., Bertolotto, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2782 · Cited by 536
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Pollak, M. N. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 507
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
Lu, Z., Luo, R. Z., Lu, Y., Zhang, X., Yu, Q., Khare, S., Kondo, S., Kondo, Y., Yu, Y., Mills, G. B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35512 · Cited by 466
White, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.025 · Cited by 413
Cancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385
Shi, W.-Y., Xiao, D., Wang, L., Dong, L.-H., Yan, Z.-X., Shen, Z.-X., Chen, S.-J., Chen, Y., & Zhao, W.-L. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.13 · Cited by 308
Bcl-2 Inhibition of Autophagy: A New Route to Cancer?
Pattingre, S., & Levine, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4412 · Cited by 306
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
Tomic, T., Botton, T., Cerezo, M., Robert, G., Luciano, F., Puissant, A., Gounon, P., Allegra, M., Bertolotto, C., Bereder, J.-M., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.86 · Cited by 301
Hadad, S., Iwamoto, T., Jordan, L., Purdie, C., Bray, S., Baker, L., Jellema, G., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
Akar, U., Chaves-Reyez, A., Barria, M., Tari, A., Sanguino, A., Kondo, Y., Kondo, S., Arun, B., Lopez-Berestein, G., & Ozpolat, B. (2008) · Autophagy · doi:10.4161/auto.6083 · Cited by 253
Deng, X.-S., Wang, S., Deng, A., Liu, B., Edgerton, S. M., Lind, S. E., Wahdan-Alaswad, R., & Thor, A. D. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18813 · Cited by 213
Nielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Methods for Assessing Autophagy and Autophagic Cell Death
Tasdemir, E., Galluzzi, L., Maiuri, M. C., Criollo, A., Vitale, I., Hangen, E., Modjtahedi, N., & Kroemer, G. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-157-4_3 · Cited by 190
Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1224-1 · Cited by 177
Yoon, S., Woo, S. U., Kang, J. H., Kim, K., Kwon, M.-H., Park, S., Shin, H.-J., Gwak, H.-S., & Chwae, Y.-J. (2010) · Autophagy · doi:10.4161/auto.6.8.13547 · Cited by 163
Premature aging in mice activates a systemic metabolic response involving autophagy induction
Mariño, G., Ugalde, A. P., Salvador-Montoliu, N., Varela, I., Quirós, P. M., Cadiñanos, J., van der Pluijm, I., Freije, J. M. P., & López-Otín, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn120 · Cited by 145
Metformin use and improved response to therapy in esophageal adenocarcinoma
Skinner, H. D., McCurdy, M. R., Echeverria, A. E., Lin, S. H., Welsh, J. W., O’Reilly, M. S., Hofstetter, W. L., Ajani, J. A., Komaki, R. R., Cox, J. D., et al. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.718096 · Cited by 113
Tang, Q., Li, G., Wei, X., Zhang, J., Chiu, J., Hasenmayer, D., Zhang, D., & Zhang, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.023 · Cited by 104
Self-citationSun, K., Guo, X.-L., Zhao, Q.-D., Jing, Y.-Y., Kou, X.-R., Xie, X.-Q., Zhou, Y., Cai, N., Gao, L., Zhao, X., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.35 · Cited by 91
Taccioli, C., Chen, H., Jiang, Y., Liu, X., Huang, K., Smalley, K. J., Farber, J. L., Croce, C. M., & Fong, L. Y. Y. (2011) · Oncogene · doi:10.1038/onc.2011.592 · Cited by 81
Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells
Chen, X., Ying, Z., Lin, X., Lin, H., Wu, J., Li, M., & Song, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68143 · Cited by 75
Timme, S., Ihde, S., Fichter, C. D., Waehle, V., Bogatyreva, L., Atanasov, K., Kohler, I., Schöpflin, A., Geddert, H., Faller, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.298 · Cited by 54
Zhao, Y., Schetter, A. J., Yang, G. B., Nguyen, G. H., Mathé, E. A., Li, P., Cai, H., Yu, L., Liu, F., Hang, D., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27954 · Cited by 52
Antitumor effect of metformin in esophageal cancer: In vitro study
Kobayashi, M., Kato, K., Iwama, H., Fujihara, S., Nishiyama, N., Mimura, S., Toyota, Y., Nomura, T., NOMURA, K., Tani, J., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1722 · Cited by 52
Cancer Prevention With a Diabetes Pill?
Taubes, G. (2012) · Science · doi:10.1126/science.335.6064.29 · Cited by 50
Cytogenetic aberrations in immortalization of esophageal epithelial cells
Zhang, H., Jin, Y., Chen, X., Jin, C., Law, S. Y.-K., Tsao, S., & Kwong, Y. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.07.016 · Cited by 49
Self-citationRoles of mTOR and STAT3 in Autophagy Induced by Telomere 3' Overhang-Specific DNA Oligonucleotides
Yokoyama, T., Kondo, Y., & Kondo, S. (2007) · Autophagy · doi:10.4161/auto.4602 · Cited by 47
Reduction of STAT3 expression induces mitochondrial dysfunction and autophagy in cardiac HL-1 cells
Elschami, M., Scherr, M., Philippens, B., & Gerardy‐Schahn, R. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.09.002 · Cited by 40
Zhang, H., Kuang, S.-Q., Liao, L., Zhou, S., & Xu, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1176 · Cited by 28
Self-citation
Cited by
MTOR: a pharmacologic target for autophagy regulation
Kim, Y. C., & Guan, K.-L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci73939 · Cited by 2,126
The role of STAT3 in autophagy
You, L., Wang, Z., Li, H., Shou, J., Jing, Z., Xie, J., Sui, X., Pan, H., & Han, W. (2015) · Autophagy · doi:10.1080/15548627.2015.1017192 · Cited by 515
mTOR Pathways in Cancer and Autophagy
Paquette, M., El-Houjeiri, L., & Pause, A. (2018) · Cancers · doi:10.3390/cancers10010018 · Cited by 297
De Meyer, G. R. Y., Grootaert, M. O. J., Michiels, C. F., Kurdi, A., Schrijvers, D. M., & Martinet, W. (2015) · Circulation Research · doi:10.1161/circresaha.116.303804 · Cited by 287
Metadata
- Authors
- Feng, Y., Ke, C., Tang, Q., Dong, H., Zheng, X., Lin, W., Ke, J., Huang, J., Yeung, S.-C., & Zhang, H.
- Venue
- Cell Death & Disease
- Published
- 2014-02-27
- Volume
- 5
- Issue
- 2
- Pages
- e1088-e1088
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W1996611359
- Cited by
- 272
- References
- 41
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.